Prognose des europäischen Marktes für Antikörperentdeckung bis 2030 – Regionale Analyse – nach Antikörpertyp (monoklonale Antikörper, polyklonale Antikörper und andere), Art (menschlich und humanisiert, chimär und murin), Dienstleistungen (Phagendisplay, Hybridom, transgenes Tier, Einzelzell- und Hefedisplay) und Endnutzer (Pharma- und Biotechnologieunternehmen, Forschungslabore und andere)
Steigende Krebsinzidenz treibt europäischen Markt für Antikörperforschung an
Nach den im Jahr 2020 veröffentlichten Schätzungen des Global Cancer Observatory (GLOBOCAN) gab es weltweit 19,3 Millionen Krebsfälle. Bis Januar 2030 wird die Zahl der Krebsüberlebenden auf 22,1 Millionen geschätzt, was in erster Linie auf die Alterung der Bevölkerung zurückzuführen ist. Lungen-, Brust-, Dickdarm-, Prostata- und Mammakarzinom gehören zu den am häufigsten gemeldeten Krebsarten. Die steigenden Krebsinzidenzen haben weltweit Besorgnis ausgelöst. Nachfolgend finden Sie die Liste der weltweit im Jahr 2020 gemeldeten häufigen Krebsfälle.
Neue Krebsfälle weltweit im Jahr 2020
Sr. Nr.
Krebsart
Anzahl der Fälle (Millionen)
1
Magen
1,09
2
Haut (kein Melanom)
1,2
3
Prostata
1,41
4
Dickdarm und Enddarm
1,93
5
Lunge
2,21
6
Brust
2,26
Quelle: Weltgesundheitsorganisation, Februar 2020
Krebs ist heute eine Lebensstilkrankheit, die häufig bei Menschen mit ungesunden Essgewohnheiten und solchen mit wenig körperlicher Betätigung auftritt. Häufiger Alkohol- und Tabakkonsum erhöht das Krebsrisiko. Chronische Infektionskrankheiten in Ländern mit niedrigem und mittlerem Einkommen können die Krebsrisikofaktoren weiter verschärfen. Ein Anstieg der Krebserkrankungen weist auf die Notwendigkeit innovativer Krebsbehandlungen hin. Monoklonale Antikörper stellen eine vielversprechende Klasse gezielter Antikrebsmittel dar, die die natürliche Fähigkeit des Immunsystems verbessern, die Aktivität von Krebszellen zu unterdrücken und Krebszellen zu eliminieren. Antikörper-Wirkstoff-Konjugate (ADCs) haben ebenfalls vielversprechende Ergebnisse in der Krebsbehandlung gezeigt. Darüber hinaus ermöglicht der Fortschritt in der modernen Biotechnologie Forschern und Unternehmen, gut konzipierte neuartige Antikörper bereitzustellen, die den Weg für erfolgreiche Behandlungen verschiedener Krebsarten ebnen. Somit fördert die zunehmende Häufigkeit verschiedener Krebsarten das Wachstum des Antikörperentdeckungsmarktes.
Überblick über den europäischen Antikörperentdeckungsmarkt
Der europäische Antikörperentdeckungsmarkt ist in Deutschland, Großbritannien, Frankreich, Italien, Spanien und den Rest Europas unterteilt. Die Region hält einen erheblichen Anteil am Weltmarkt. Aufgrund der zunehmenden Verwendung monoklonaler Antikörper in F&E-Anwendungen, Krebstherapien und der Behandlung immunologischer Störungen wird in den kommenden Jahren ein starkes Wachstum erwartet. Darüber hinaus werden der steigende Bedarf an Patientendatenverwaltungssystemen, die Prävalenz chronischer Krankheiten und staatliche Initiativen zur Implementierung von Antikörperdiensten voraussichtlich Wachstumschancen für den Markt für Antikörperentdeckung in Ländern wie Frankreich, Italien und Spanien bieten.
Umsatz und Prognose des europäischen Marktes für Antikörperentdeckung bis 2030 (Milliarden US-Dollar)
Segmentierung des europäischen Marktes für Antikörperentdeckung
Der europäische Markt für Antikörperentdeckung ist nach Antikörpertyp, Art, Diensten, Endbenutzer und Land kategorisiert.
Basierend auf dem Antikörpertyp ist der europäische Markt für Antikörperentdeckung in monoklonale Antikörper, polyklonale Antikörper und andere segmentiert. Das Segment monoklonale Antikörper hatte 2022 den größten Marktanteil an der Antikörperentdeckung in Europa.
In Bezug auf die Art ist der europäische Markt für Antikörperentdeckung in humane und humanisierte, chimäre und murine Antikörper segmentiert. Das Segment humane und humanisierte Antikörper hatte 2022 den größten Marktanteil an der Antikörperentdeckung in Europa.
Nach Dienstleistungen ist der europäische Markt für Antikörperentdeckung in Phagendisplay, Hybridom, transgene Tiere, Einzelzellen und Hefedisplay unterteilt. Das Segment Phagendisplay hatte 2022 den größten Marktanteil an der Antikörperentdeckung in Europa.
Basierend auf dem Endverbraucher ist der europäische Markt für Antikörperentdeckung in Pharma- und Biotechnologieunternehmen, Forschungslabore und andere unterteilt. Das Segment Pharma- und Biotechnologieunternehmen hatte 2022 den größten Marktanteil an der Antikörperentdeckung in Europa.
Basierend auf den Ländern ist der europäische Markt für Antikörperentdeckung in Deutschland, Großbritannien, Frankreich, Italien, Spanien und das übrige Europa unterteilt. Deutschland dominierte im Jahr 2022 den europäischen Markt für Antikörperentdeckung.
Charles River Laboratories International Inc, Creative Biolabs Inc, Evotec SE, Sartorius AG, Aragen Life Sciences Ltd, Twist Bioscience Corp und Biocytogen Pharmaceuticals Beijing Co Ltd. sind einige der führenden Unternehmen auf dem europäischen Markt für Antikörperentdeckung.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Antibody Discovery Market - Key Market Dynamics
4.1 Market Drivers
4.1.1 Increasing Investments in Research & Development
4.1.2 Rising Incidence of Cancer
4.2 Market Restraints
4.2.1 High Cost of Production
4.3 Market Opportunities
4.3.1 Proliferation of Biotechnology Industry in Developing Regions
4.4 Future Trends
4.4.1 Developments for Custom Antibodies
4.5 Impact of Drivers and Restraints:
5. Antibody Discovery Market - Europe Market Analysis
5.1 Europe Antibody Discovery Market Revenue (US$ Million), 2020-2030
6. Europe Antibody Discovery Market Analysis - by Antibody Type
6.1 Overview
6.2 Monoclonal Antibodies
6.2.1 Overview
6.2.2 Monoclonal Antibodies: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
6.3 Polyclonal Antibodies
6.3.1 Overview
6.3.2 Polyclonal Antibodies: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Others
6.4.1 Overview
6.4.2 Others: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
7. Europe Antibody Discovery Market Analysis - by Nature
7.1 Overview
7.2 Human and Humanized
7.2.1 Overview
7.2.2 Human and Humanized: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Chimeric
7.3.1 Overview
7.3.2 Chimeric: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Murine
7.4.1 Overview
7.4.2 Murine: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8. Europe Antibody Discovery Market Analysis - by Services
8.1 Overview
8.2 Phage Display
8.2.1 Overview
8.2.2 Phage Display: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Hybridoma
8.3.1 Overview
8.3.2 Hybridoma: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Transgenic Animal
8.4.1 Overview
8.4.2 Transgenic Animal: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Yeast Display
8.5.1 Overview
8.5.2 Yeast Display: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Single Cell
8.6.1 Overview
8.6.2 Single Cell: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
9. Europe Antibody Discovery Market Analysis - by End User
9.1 Overview
9.2 Pharmaceutical and Biotechnology Companies
9.2.1 Overview
9.2.2 Pharmaceutical and Biotechnology Companies: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
9.3 Research Laboratories
9.3.1 Overview
9.3.2 Research Laboratories: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Others
9.4.1 Overview
9.4.2 Others: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
10. Europe Antibody Discovery Market - Country Analysis
10.1 Europe Antibody Discovery Market, Revenue and Forecast to 2030
10.1.1 Europe: Antibody Discovery Market - Revenue and Forecast Analysis - by Country
10.1.1.1 UK
10.1.1.1.1 Overview
10.1.1.1.2 UK: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.3 UK: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.1.4 UK: Antibody Discovery Market Breakdown, by Nature
10.1.1.1.5 UK: Antibody Discovery Market Breakdown, by Services
10.1.1.1.6 UK: Antibody Discovery Market Breakdown, by End User
10.1.1.2 Germany
10.1.1.2.1 Overview
10.1.1.2.2 Germany: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.3 Germany: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.2.4 Germany: Antibody Discovery Market Breakdown, by Nature
10.1.1.2.5 Germany: Antibody Discovery Market Breakdown, by Services
10.1.1.2.6 Germany: Antibody Discovery Market Breakdown, by End User
10.1.1.3 France
10.1.1.3.1 Overview
10.1.1.3.2 France: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.3 France: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.3.4 France: Antibody Discovery Market Breakdown, by Nature
10.1.1.3.5 France: Antibody Discovery Market Breakdown, by Services
10.1.1.3.6 France: Antibody Discovery Market Breakdown, by End User
10.1.1.4 Italy
10.1.1.4.1 Overview
10.1.1.4.2 Italy: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.3 Italy: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.4.4 Italy: Antibody Discovery Market Breakdown, by Nature
10.1.1.4.5 Italy: Antibody Discovery Market Breakdown, by Services
10.1.1.4.6 Italy: Antibody Discovery Market Breakdown, by End User
10.1.1.5 Spain
10.1.1.5.1 Overview
10.1.1.5.2 Spain: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.3 Spain: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.5.4 Spain: Antibody Discovery Market Breakdown, by Nature
10.1.1.5.5 Spain: Antibody Discovery Market Breakdown, by Services
10.1.1.5.6 Spain: Antibody Discovery Market Breakdown, by End User
10.1.1.6 Rest of Europe
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.3 Rest of Europe: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.6.4 Rest of Europe: Antibody Discovery Market Breakdown, by Nature
10.1.1.6.5 Rest of Europe: Antibody Discovery Market Breakdown, by Services
10.1.1.6.6 Rest of Europe: Antibody Discovery Market Breakdown, by End User
11. Antibody Discovery Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Antibody Discovery Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Charles River Laboratories International Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Creative Biolabs Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Evotec SE
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Sartorius AG
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Aragen Life Sciences Ltd
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Twist Bioscience Corp
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Biocytogen Pharmaceuticals Beijing Co Ltd
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
List of Tables
Table 1. Europe Antibody Discovery Market Segmentation
Table 2. New Cancer Cases Worldwide, in 2020
Table 3. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
Table 4. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
Table 5. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
Table 6. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 7. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
Table 8. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
Table 9. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
Table 10. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 11. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
Table 12. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
Table 13. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
Table 14. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 15. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
Table 16. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
Table 17. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
Table 18. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 19. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
Table 20. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
Table 21. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
Table 22. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 23. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
Table 24. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
Table 25. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
Table 26. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 27. Recent Inorganic Growth Strategies in the Antibody Discovery Market
Table 28. Recent Organic Growth Strategies in the Antibody Discovery Market
Table 29. Glossary of Terms, Antibody Discovery Market
List of Figures
Figure 1. Europe Antibody Discovery Market Segmentation, by Country
Figure 2. Europe Antibody Discovery Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Europe Antibody Discovery Market Revenue (US$ Million), 2020 - 2030
Figure 5. Europe Antibody Discovery Market Share (%) - by Antibody Type (2022 and 2030)
Figure 6. Monoclonal Antibodies: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Polyclonal Antibodies: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Others: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Europe Antibody Discovery Market Share (%) - by Nature (2022 and 2030)
Figure 10. Human and Humanized: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Chimeric: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Murine: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Europe Antibody Discovery Market Share (%) - by Services (2022 and 2030)
Figure 14. Phage Display: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Hybridoma: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Transgenic Animal: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Yeast Display: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Single Cell: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Europe Antibody Discovery Market Share (%) - by End User (2022 and 2030)
Figure 20. Pharmaceutical and Biotechnology Companies: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Research Laboratories: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Others: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Europe: Antibody Discovery Market, by Key Country - Revenue (2022) (US$ Million)
Figure 24. Europe: Antibody Discovery Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 25. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
Figure 26. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
Figure 27. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
Figure 28. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
Figure 29. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
Figure 30. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
Figure 31. Growth Strategies in the Antibody Discovery Market
- Charles River Laboratories International Inc
- Creative Biolabs Inc
- Evotec SE
- Sartorius AG
- Aragen Life Sciences Ltd
- Twist Bioscience Corp
- Biocytogen Pharmaceuticals Beijing Co Ltd
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe antibody discovery market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Europe antibody discovery market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe antibody discovery market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.